Mechanical circulatory support: Measures of adjustment and quality of life

机械循环支持:调整措施和生活质量

基本信息

  • 批准号:
    9892884
  • 负责人:
  • 金额:
    $ 63.33万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-03-07 至 2023-02-28
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): There is a critical need to develop better measures to assess adjustment to mechanical circulatory support (MCS) and health-related quality of life (HRQOL) because the impact of this therapy on patients' lives is profound. MCS devices are implanted surgically in patients with advanced heart failure and help the heart pump blood throughout the body. After discharge from the hospital, patients manage and troubleshoot their MCS devices while returning, as best they can, to usual activities of daily living (e.g., home and family responsibilities, work, and recreation). Benefits of MCS include longer survival (as compared to medical management of advanced heart failure), reduced heart failure symptoms, and improved physical function. Device-related complications (including bleeding, infection, device malfunction, and stroke) are risks of MCS implantation. As MCS technology evolves, survival is improving and the risk of adverse events is decreasing. However, future recommendations on the advisability of this expensive technology will depend not only on survivability and the risk of adverse events, but also on other outcomes, such as adjustment to MCS and HRQOL, which are less well defined. Importantly, currently available HRQOL instruments, which are generic or designed for heart failure or other illnesses, do not address many of the issues of concern and unique burdens of MCS on patients' daily lives. Currently, 50,000 to 100,ooo patients are diagnosed with advanced heart failure annually. Given the limited availability of heart transplantation, advanced heart failure patients may be offered MCS as a permanent implant (i.e., destination therapy). We propose to develop an MCS-specific measurement system, which we will refer to as Mechanical Circulatory Support: Adjustment and Quality of Life (MCS A-QOL). Our study design will focus on development and psychometric testing of our MCS A-QOL measurement system and evaluation of our conceptual model, followed by an exploration of usability of our measures (via a mobile app) by patients and providers. With development of a measurement system, our research will advance the field of MCS in patients with advanced heart failure. Use of our valid and responsive MCS A-QOL measures will contribute significantly to more clearly defining the benefits and risks of this evolving technology as compared with medical therapy or other strategies. Thus, "survival" will become more meaningful, as MCS A-QOL is incorporated into our understanding of risks and benefits.


项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Validity of Patient-Reported Outcomes Measurement Information System Physical, Mental, and Social Health Measures After Left Ventricular Assist Device Implantation and Implications for Patient Care.
  • DOI:
    10.1161/circoutcomes.121.008690
  • 发表时间:
    2023-03
  • 期刊:
  • 影响因子:
    6.9
  • 作者:
    Hahn, Elizabeth A.;Walsh, Mary N.;Allen, Larry A.;Lee, Christopher S.;Denfeld, Quin E.;Teuteberg, Jeffrey J.;Beiser, David G.;McIlvennan, Colleen K.;Lindenfeld, JoAnn;Klein, Liviu;Adler, Eric D.;Stehlik, Josef;Ruo, Bernice;Bedjeti, Katy;Cummings, Peter D.;Vela, Alyssa M.;Grady, Kathleen L.
  • 通讯作者:
    Grady, Kathleen L.
PROMIS: Physical, Mental and Social Health Outcomes Improve From Before to Early After LVAD Implant: Findings From the Mechanical Circulatory Support: Measures of Adjustment and Quality of Life (MCS A-QOL) Study.
PROMIS:从 LVAD 植入前到植入后早期,身体、心理和社会健康结果均有所改善:机械循环支持的发现:调整和生活质量的测量 (MCS A-QOL) 研究。
  • DOI:
    10.1016/j.cardfail.2023.03.013
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    6
  • 作者:
    Hahn,ElizabethA;Allen,LarryA;Lee,ChristopherS;Denfeld,QuinE;Stehlik,Josef;Cella,David;Lindenfeld,Joann;Teuteberg,JeffreyJ;McIlvennan,ColleenK;Kiernan,MichaelS;Beiser,DavidG;Walsh,MaryN;Adler,EricD;Ruo,Bernice;Kirklin,
  • 通讯作者:
    Kirklin,
Research engagement and experiences of patients pre- and post-implant of a left ventricular assist device from the mechanical circulatory support measures of adjustment and quality of life (MCS A-QOL) study.
  • DOI:
    10.1007/s11136-022-03111-4
  • 发表时间:
    2022-08
  • 期刊:
  • 影响因子:
    3.5
  • 作者:
    Carroll, Allison J.;Hahn, Elizabeth A.;Grady, Kathleen L.
  • 通讯作者:
    Grady, Kathleen L.
Novel measures to assess ventricular assist device patient-reported outcomes: Findings from the MCS A-QOL study.
评估心室辅助装置患者报告结果的新方法:MCS A-QOL 研究的结果。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KATHLEEN L GRADY其他文献

KATHLEEN L GRADY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KATHLEEN L GRADY', 18)}}的其他基金

Mechanical circulatory support: Measures of adjustment and quality of life
机械循环支持:调整措施和生活质量
  • 批准号:
    9237297
  • 财政年份:
    2016
  • 资助金额:
    $ 63.33万
  • 项目类别:
Sustaining quality of life of the aged: Heart transplant or mechanical support?
维持老年人的生活质量:心脏移植还是机械支持?
  • 批准号:
    9110086
  • 财政年份:
    2015
  • 资助金额:
    $ 63.33万
  • 项目类别:
Sustaining quality of life of the aged: Heart transplant or mechanical support?
维持老年人的生活质量:心脏移植还是机械支持?
  • 批准号:
    9263873
  • 财政年份:
    2015
  • 资助金额:
    $ 63.33万
  • 项目类别:
Pediatric Heart Tranplantation: Transitioning to Adult Care
儿童心脏移植:过渡到成人护理
  • 批准号:
    8445845
  • 财政年份:
    2013
  • 资助金额:
    $ 63.33万
  • 项目类别:
Pediatric Heart Tranplantation: Transitioning to Adult Care
儿童心脏移植:过渡到成人护理
  • 批准号:
    8699823
  • 财政年份:
    2013
  • 资助金额:
    $ 63.33万
  • 项目类别:
QUALITY OF LIFE OUTCOMES >= 5 YRS POST HEART TRANSPLANT
心脏移植后 5 年以上的生活质量结果
  • 批准号:
    6343792
  • 财政年份:
    2000
  • 资助金额:
    $ 63.33万
  • 项目类别:
QUALITY OF LIFE OUTCOMES >= 5 YRS POST HEART TRANSPLANT
心脏移植后 5 年以上的生活质量结果
  • 批准号:
    6090391
  • 财政年份:
    2000
  • 资助金额:
    $ 63.33万
  • 项目类别:
QUALITY OF LIFE OUTCOMES >= 5 YRS POST HEART TRANSPLANT
心脏移植后 5 年以上的生活质量结果
  • 批准号:
    6490856
  • 财政年份:
    2000
  • 资助金额:
    $ 63.33万
  • 项目类别:
QUALITY OF LIFE OUTCOMES >= 5 YRS POST HEART TRANSPLANT
心脏移植后 5 年以上的生活质量结果
  • 批准号:
    6627631
  • 财政年份:
    2000
  • 资助金额:
    $ 63.33万
  • 项目类别:
QUALITY OF LIFE OUTCOMES >= 5 YRS POST HEART TRANSPLANT
心脏移植后 5 年以上的生活质量结果
  • 批准号:
    6690746
  • 财政年份:
    2000
  • 资助金额:
    $ 63.33万
  • 项目类别:

相似海外基金

Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
  • 批准号:
    10707830
  • 财政年份:
    2023
  • 资助金额:
    $ 63.33万
  • 项目类别:
Hospital characteristics and Adverse event Rate Measurements (HARM) Evaluated over 21 years.
医院特征和不良事件发生率测量 (HARM) 经过 21 年的评估。
  • 批准号:
    479728
  • 财政年份:
    2023
  • 资助金额:
    $ 63.33万
  • 项目类别:
    Operating Grants
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
分析 ECOG-ACRIN 不良事件数据,以优化在不断发展的癌症治疗范式 (EVOLV) 背景下纵向耐受性评估的策略
  • 批准号:
    10884567
  • 财政年份:
    2023
  • 资助金额:
    $ 63.33万
  • 项目类别:
AE2Vec: Medical concept embedding and time-series analysis for automated adverse event detection
AE2Vec:用于自动不良事件检测的医学概念嵌入和时间序列分析
  • 批准号:
    10751964
  • 财政年份:
    2023
  • 资助金额:
    $ 63.33万
  • 项目类别:
Understanding the real-world adverse event risks of novel biosimilar drugs
了解新型生物仿制药的现实不良事件风险
  • 批准号:
    486321
  • 财政年份:
    2022
  • 资助金额:
    $ 63.33万
  • 项目类别:
    Studentship Programs
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
  • 批准号:
    10676786
  • 财政年份:
    2022
  • 资助金额:
    $ 63.33万
  • 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
  • 批准号:
    10440970
  • 财政年份:
    2022
  • 资助金额:
    $ 63.33万
  • 项目类别:
Improving Adverse Event Reporting on Cooperative Oncology Group Trials
改进肿瘤学合作组试验的不良事件报告
  • 批准号:
    10642998
  • 财政年份:
    2022
  • 资助金额:
    $ 63.33万
  • 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
  • 批准号:
    10482465
  • 财政年份:
    2022
  • 资助金额:
    $ 63.33万
  • 项目类别:
Expanding and Scaling Two-way Texting to Reduce Unnecessary Follow-Up and Improve Adverse Event Identification Among Voluntary Medical Male Circumcision Clients in the Republic of South Africa
扩大和扩大双向短信,以减少南非共和国自愿医疗男性包皮环切术客户中不必要的后续行动并改善不良事件识别
  • 批准号:
    10191053
  • 财政年份:
    2020
  • 资助金额:
    $ 63.33万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了